🚀 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐖𝐞𝐞𝐤 is almost here—and it’s not just a conference; it’s a defining experience for the future of advanced therapies. Join us 𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝟐𝟎 - 𝟐𝟑 𝐢𝐧 𝐃𝐚𝐥𝐥𝐚𝐬, 𝐓𝐞𝐱𝐚𝐬, for the largest gathering of 𝐜𝐞𝐥𝐥 & 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬, featuring thought leaders from the hashtag #FDA, the University of Pennsylvania, Bluebird Bio, Cellectis, Kite Pharma, Novo Nordisk Cellerator, and more. 𝐓𝐚𝐤𝐞 𝐚 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐚𝐠𝐞𝐧𝐝𝐚 & 𝐟𝐢𝐧𝐝 𝐭𝐢𝐜𝐤𝐞𝐭𝐬 𝐡𝐞𝐫𝐞: https://lnkd.in/gtWje5G9 This is your chance to connect with global innovators, researchers, and industry leaders shaping the future of CGT and biotech.
Pharma Focus America’s Post
More Relevant Posts
-
🧬 Diagnostic Expert & Northwest Regional Manager @Viracor | Healthcare Innovation through Same-Day Testing Results
⚠️ TA-TMA Webinar ⚠️ Don’t miss this! There has been so much going on this week with Laboratory Appreciation week & now this AWESOME webinar with Dr. Sabulski! Let’s elevate patient care together 🤝 #BoneMarrowTransplant #Transplantation #Hematology #Oncology
🚨 ALERT 🩺 Our TA-TMA WEBINAR is tomorrow! 📅 Wednesday, April 17th 12-1pm CST. 📺 The Past, Present & Future of TA-TMA Targeted Therapies. Presented by Anthony Sabulski, MD and moderated by Steve Kleiboeker, DVM, PhD. REGISTER NOW 👇 https://lnkd.in/gDrf6fZM #bmt #ATC2024Philly #HSCT Sonata Jodele
-
Granger Genetics’ Asparaginase Panel Assay helps physicians make informed decisions about treatment by detecting antibodies that may impact therapy. This valuable tool supports clinicians in evaluating the presence of antibodies and determining the best path forward for their patients. #AsparaginaseTesting #BloodCancerAwareness #GrangerGenetics
-
-
Self-Published Author of “Killing Cancer with TILs”. Inspirational Speaker, Autologous CELL Therapy Proof Of Concept for Solid Tumors, Rare Melanoma Survivor Thriver & Advocate, Clinical Trial Volunteer, & Giver of Hope
The full agenda for #ATW25 has been released!! Join myself and Karrie Wong from KSQ Therapeutics, Inc. on Jan 22, 2025 from 5-6pm in Theater 6 for our session focused on Patient Considerations titled “TILs-The Promise to Patients of Cell Therapies” My session is 1 of 3 to choose from on the last full day of this conference prior to the evening Advanced Therapies Awards ceremony from 7:30-11pm. One thing I can guarantee is I Promise, You Will Not Want To Miss This! If you have ever met me, spoke , or talked to me, then you know that I have A LOT to say, and I’m VERY passionate about saying it. View the full agenda here: https://ow.ly/lGGR50TLIrw Explore: ✅Sessions on the latest in cell and gene therapy ✅Key industry challenges and breakthrough solutions ✅A chance to connect with the most influential leaders in the space I can’t wait to be part of this game-changing event in Dallas! If you haven’t yet, Grab your ticket here 👇 https: //ow.ly/Z4Ff50TLIl2 I have multiple sessions I am looking forward to attending in the first three days. What I want to know is what sessions are you looking forward to and why? Drop a word or two in the comments and let’s chat about where you hurt is and how to ease pain. #ATW25 #AdvancedTherapies #Biotech #Dallas #Networking #Innovation #Speaker #yourTILspeaker #MucosalMelanomaSurvivor
I'm speaking at Advanced Therapies Week 2025, join me
invt.io
-
Characterization of #omalizumab updosing patterns and predictive factors in #chronic #spontaneous #urticaria: A prospective multicentric observational stud. Open Access. https://lnkd.in/dV2vG2FU
-
-
Streamlining immune #celltherapymanufacturing workflows with single-use #cytokines Transitioning an #immunecelltherapy program from research to the clinic requires consistent and scalable #cellmanufacturing processes. This month, join Gabriella Perell (Global Strategic Senior Product Manager, Bio-Techne) as she examines the workflow difficulties posed by traditional #cytokinedelivery. She will also discuss the benefits of transitioning to a single-use cytokine method. Attend to learn about: • Workflow difficulties posed by traditional cytokine delivery • Benefits of transitioning to a single-use cytokine method • The need for scalable, aseptic closed-systems for immune cell manufacturing Register for this upcoming #webinar below:
Online Event
-
Discover how Granger Genetics is revolutionizing treatment with our advanced assays. Our L-asparaginase activity test detects 'silent inactivation', optimizing enzyme activity for better outcomes. Physicians, enhance your patients' journey with our cutting-edge tools. Contact us now to learn more! 🧬 #GrangerGenetics #PrecisionMedicine
-
-
Global Executive Medtech Business Leader | MBA & MBA Extension | Marketing & Commercial | Global Experience | EMEA, UK, USA | Business Transformation & Strategic Solutions | Value Based & Digital Strategies
Excited to share this post featuring Professor Angela Dispenzieri, about the benefits of Mass Spectrometry.
The use of novel, highly effective therapies has led to significant improvements in Multiple Myeloma patient response rates, with more patients achieving undetectable M-protein levels. Watch this video to learn more from Professor Angela Dispenzieri, about the benefits of Mass Spectrometry, a cutting-edge solution enabling M-protein measurement in serum, with a sensitivity and specificity beyond conventional methods.
-
Last night on 60 MINUTES, Alexandra Snyder, MD, our EVP of R&D, sat down with Bill Whitaker to share our patient-first approach to healthcare: “We’re taking what’s known and we’re really pushing the field; we’re pushing the biology to make drugs that look like regular drugs, but function even better.” Discover how we’re harnessing #AI to instantly generate optimal therapeutics, aiming for the greatest impact on human health. https://lnkd.in/ebSqSawE #GenerativeAI | #ProteinEngineering
60 Minutes (@60Minutes) on X
twitter.com
-
Generate:Biomedicines thanks for featuring the Synergy Neo2 at 0:12 on 60 MINUTES. https://lnkd.in/gNu6NSDP Listen to Dr. Alexandra Snyder and Generate:Biosciences harness #AI to generate insight with the greatest impact on human health.
Last night on 60 MINUTES, Alexandra Snyder, MD, our EVP of R&D, sat down with Bill Whitaker to share our patient-first approach to healthcare: “We’re taking what’s known and we’re really pushing the field; we’re pushing the biology to make drugs that look like regular drugs, but function even better.” Discover how we’re harnessing #AI to instantly generate optimal therapeutics, aiming for the greatest impact on human health. https://lnkd.in/ebSqSawE #GenerativeAI | #ProteinEngineering
60 Minutes (@60Minutes) on X
twitter.com
-
Discover the latest advancements in predicting preeclampsia risk through innovative biomarker testing in this insightful article from ADLM Clinical Laboratory News. The article collects opinions from key thought leaders on the use of this "game-changer" test and discusses ACOG's recent guidance. Learn more: https://lnkd.in/ekaNBDMV #PrenatalCare #Preeclampsia #MaternalHealth #thermofisheremp
-
